# Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

> **NCT04173637** · PHASE2 · COMPLETED · sponsor: **Akeso** · enrollment: 330 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **BIOLOGICAL:** AK101
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04173637
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-19
- **Primary completion:** 2022-03-03
- **Final completion:** 2022-03-03
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173637, "Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04173637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*